Phathom Pharmaceuticals, Inc. Share Price & Technical Analysis
PHAT · $11.33 (-2.16%)
Healthcare / Biotechnology
$11.33
-2.16%
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed …
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
-2% return in May, 7% avg return in past 3 year May month.
-35% return in 2026, 66% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -18% | -7% | -8% | 0% | -2% | – | – | – | – | – | – | – | -35% |
| 25 | -27% | -5% | 15% | -26% | 5% | 123% | -11% | 45% | -2% | 14% | 16% | 9% | 156% |
| 24 | -26% | 57% | -1% | -15% | 4% | 7% | 15% | 39% | 10% | -5% | -49% | -8% | 29% |
| 23 | 3% | -28% | -15% | 53% | 10% | 21% | 6% | -3% | -28% | -11% | -25% | 30% | 14% |
| 22 | -15% | 8% | -25% | -5% | -45% | 17% | 10% | -8% | 32% | -5% | -7% | 12% | -32% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$976.21M
P/E ratio
—
52W high
$18.31
52W low
$3.92
Volume
7,59,741
Beta
0.57
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Phathom Pharmaceuticals, Inc. share price today?
- Phathom Pharmaceuticals, Inc. (PHAT) last traded around $11.33 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PHAT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PHAT. Download the app for real-time alerts.
- How can I analyze Phathom Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.